Epidemic proportions

There is currently no proven vaccine, no federal funding for medical research, and no media onslaught of concerned scientists. Nevertheless, the condition is a troubling and widespread epidemic.

Seemingly limited to a narrow generation and gender demographic – young males ages 14 to 25 – the complaint crosses all socio-economic boundaries, affecting several ethnic and cultural classifications, but is particularly prevalent in American youths.

Anecdotal evidence shows questionable results from varying treatments, and reported relapses are common in a majority of cases.

While controversial, a promising new and cost-effective application for alleviating Gluteus Maximus Crevice Exposure is an industrial stapler.

I’ve been a 100 Word nerd for a long time, submitting my first attempt in January 2010 while still writing on my former blog, “If Mom Says OK.” When Vel gave us our prompt for this week, Rework, and challenged us to “shake things up,” I thought I would bring back one of my early entries and… wait for it… rework it. The original 100 words was published on IMSO a little more than three years ago. I’ll leave it to you, dear readers, to decide which 100 Word version you prefer.

Epidemic proportions

By Tara R., If Mom Says OK
June 9, 2010

There is no vaccine, no medical research in place, no media onslaught of concerned scientists, but it is no less an epidemic, nay… pandemic!

The ailment seems to be limited to one demographic – young men between the ages of 14 and 25. It crosses all socio-economic boundaries, affects all ethnic and cultural classifications, but appears to present in American males more than other nationalities.

Treatments vary, with questionable results. Relapses are common and, in a majority of cases, more acute than when first presented.

While controversial, one promising application for alleviating gluteus maximus crevice exposure is an industrial stapler.